Several different serological procedures are employed for the identification of Haemophilus influenza type b (HIB) organisms or their soluble antigenic components. These include the Quellung reaction (1), precipitin and slide agglutination tests (2, 9) , countercurrent immunoelectrophoretic techniques (3, 8) and immunofluorescence microscopy (4, 7) . Most of these procedures are relatively time-consuming or expensive or require considerable technical expertise. Because of its simplicity and cost effectiveness, the slide agglutination test (2) that uses typespecific antisera with bacteria isolated from clinical specimens is the method most commonly employed today.
A Phadebact test for the rapid identification of HIB organisms has been developed by Pharmacia Diagnostics, Uppsala, Sweden. This procedure is based on the coagglutination principle first described by Kronvall (5 Coagglutination tests were performed by placing drops of type b and non-type b reagents on a glass slide. Bacteria from an area of dense growth were mixed into each drop with an inoculating loop. Agglutination tests were per-formed by mixing a similar amount of bacteria with a drop of antiserum prepared against a, b, or c serotypes (Difco). Ail slides were rocked manually at room temperature for 2 min and then observed macroscopically for positive and negative reactions (Fig. 1) . The positive coagglutination reactions produced with the type b reagent developed immediately after mixing, whereas 1 to 2 min elapsed before the positive agglutination reactions became observable. More importantly for ease of detection, the positive agglutination reaction was highly visible and was distinguished clearly from negative reactions. Figure 1 also shows a positive coagglutination reaction when type a organisms were mixed with the non-type b reagent.
The coagglutination test was compared with the agglutination test in the same experiment designed to identify b serotypes among the 195 strains. produce positive reactions. Then, 2-fold dilutions were made over a range encompassing the approximations, and the tests were conducted again. Table 2 shows that ca. 1010 bacteria per ml were required to achieve positive agglutination reactions. In contrast, only ca. 10' bacteria per ml or less were required to achieve positive coagglutination reactions. These findings demonstrate that the coagglutination test was at least 100-to 200-fold more sensitive than the agglutination test. Relative to saline, the sensitivities of both tests were not increased or decreased to any great degree by substances present in the pooled biological fluids. Although the coagglutination procedure was designed for identifying HIB isolated from clinical specimens, it may be possible to improve its sensitivity further to test clinical specimens directly, providing that the bacterial cell density is high enough. Taken together, our results demonstrate that the Phadebact coagglutination test is more rapid and more sensitive and produces more visible clumping reactions than the slide agglutination test in identifying HIB organisms isolated from clinical specimens.
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